3.6. Drug sensitivity analysis of the risk score
The “pRRophetic” package was performed to investigate the correction between drug sensitivity and risk score. IC50 of cisplatin was lower in low-risk group compared to high-risk group (The IC50 of cisplatin (A) and gemcitabine (B) in high- and low-risk groups. IC50 = half-maximal inhibitory concentration.